Wolverine
A research blend of BPC-157 and TB-500 (thymosin beta-4). Investigated for tissue repair pathways, tendon and ligament healing models, gastrointestinal mucosal integrity, and actin cytoskeleton regulation.
Unit Price
Sign in to view pricing.
Purchase requires a verified researcher account and a signed RUO attestation.
All batch test results and certificates of analysis are published below — including any batches that failed testing. Full transparency is our standard.
Mechanism of Action
Wolverine blends BPC-157 and TB-500 to cover complementary repair mechanisms. BPC-157 promotes angiogenesis via VEGFR2 signaling and the Akt-eNOS axis, upregulates GH receptor expression, and supports GI mucosal integrity through nitric oxide system modulation. TB-500 (N-acetylated 17-23 fragment of thymosin beta-4, Ac-LKKTETQ) sequesters G-actin, enabling cell migration essential to tissue repair, and exhibits anti-inflammatory activity.
Research References
Full research page →Vasireddi N et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. J Am Acad Orthop Surg. 2025
Sikiric P et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia-reperfusion in rats
Philp D et al. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004. PMID: 15037013
Bhatia D et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. 2025
Related Products
Batch History & Certificates of Analysis
Full Batch Record
Active Batches
WOLV10-2026-001
Received Apr 15, 2026
Qty Received
20 units
No test results on record for this batch.
For Research Use Only. This product is supplied exclusively for in vitro research, laboratory study, and experimental purposes. It is not a drug, supplement, food, or cosmetic, and is not intended for human or veterinary use. See our Compliance & RUO Policy.